IGF1R and cancer: The modest response to GC/IGF-1R inhibitor combination in H2122 may be explained by the pre-existing dependency of this cell line on IGF-1R signalling in absence of GCs, as suggested by the data available on The Cancer Dependency Map portal24 (Supplementary Fig. 3e).